Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse
NCT ID: NCT03035877
Last Updated: 2024-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
183 participants
INTERVENTIONAL
2017-08-28
2023-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
NCT02672150
Enhancing Adolescent Substance Abuse Treatment
NCT03249350
Reducing Drug Use in Justice-Involved Emerging Adults
NCT05834881
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
NCT06236100
Early Intervention for Minors in Possession of Alcohol/Drugs: A Feasibility Study
NCT01616212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed study will evaluate the effectiveness of MST-EA for reducing justice involvement and AOD abuse. EAs (n = 240) with AOD abuse and justice involvement (recent arrests or release from justice facilities) will be randomized to receive MST-EA or Enhanced Treatment as Usual (E-TAU). Assessments will be completed at months 0, 2, 4, 6, 8, 12, and 16, with confirmation of outcome data using official records. Aims will be to evaluate the effect over time of MST-EA for reducing AOD abuse and criminal activity, as well as to evaluate the effect of MST-EA on the key proximal target of treatment (self-regulation) and intermediate outcomes of treatment (gainful activities). A final aim of the study will be to investigate if the direct effect of treatment on criminal activity is mediated by its effect on self-regulation, AOD abuse, and gainful activities. In this specific age group, there is a complete absence of AOD abuse and recidivism reduction treatments with demonstrated effectiveness. The ultimate effect of the proposed research would be decreased AOD abuse and justice involvement in a high-risk population, as well as improved outcomes that have significant societal impact (e.g., reduced homelessness and unemployment).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multisystemic Therapy-Emerging Adults
This group will receive Multisystemic Therapy-Emerging Adults.
Multisystemic Therapy-Emerging Adults
MST-EA is a home- and community-based treatment for emerging adults (ages 17-21) that aims to address antisocial behavior and problems caused by substance use disorders. The model also addresses co-occurring mental health problems when present. Therapists work directly with the young adult and his/her social network. This treatment also involves the use of coaches who help young people develop skills for young adulthood.
Enhanced Treatment as Usual
This group will have access to an enhanced version of services typically delivered to young adults who have a substance use disorder and have been in trouble with the law.
Enhanced Treatment as Usual
With Enhanced Treatment as Usual (E-TAU), emerging adults will get the treatments that they usually receive when they have a substance use disorder and have been in trouble with the law. In addition, they will receive travel vouchers for attending services, a card with an individualized list of contacts when in crisis, and facilitation with identifying need of services and accessing those services.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multisystemic Therapy-Emerging Adults
MST-EA is a home- and community-based treatment for emerging adults (ages 17-21) that aims to address antisocial behavior and problems caused by substance use disorders. The model also addresses co-occurring mental health problems when present. Therapists work directly with the young adult and his/her social network. This treatment also involves the use of coaches who help young people develop skills for young adulthood.
Enhanced Treatment as Usual
With Enhanced Treatment as Usual (E-TAU), emerging adults will get the treatments that they usually receive when they have a substance use disorder and have been in trouble with the law. In addition, they will receive travel vouchers for attending services, a card with an individualized list of contacts when in crisis, and facilitation with identifying need of services and accessing those services.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent arrest or release from jail/prison/detention (within the past 18 months but excluding arrest for parole/probation violations)
* Presence of alcohol or drug (AOD) abuse disorder and recent AOD use (within the past 90 days)
* Able to reside in a stable community setting (not currently homeless, not currently in-patient; can include individuals ready for discharge to the community)
Exclusion Criteria
* Pervasive Development Disorders (PDD) or mental retardation
* Sex offending as the primary offense type
16 Years
26 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Worcester
OTHER
Connecticut Department of Children and Families
UNKNOWN
North American Family Institute
UNKNOWN
Court Support Services Division
UNKNOWN
Youth Villages
OTHER
Chestnut Health Systems
OTHER
Oregon Social Learning Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ashli Sheidow
Senior Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashli J Sheidow, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Chestnut Health Systems
Maryann Davis, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Massachusetts, Worcestor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North American Family Institute
Hamden, Connecticut, United States
North American Family Institute
Hartford, Connecticut, United States
North American Family Institute
New Haven, Connecticut, United States
Youth Villages
Johnson City, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.